Position in TOVX
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$2
+$0 QoQ
Shares Held
11
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 20 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TOVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026IFP Advisors, Inc holds $42,061,497 across 206 Biotechnology names. TOVX ranks #205 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
60,994 | $10,309,205 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
39,148 | $7,400,929 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
206,538 | $6,861,192 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
327,791 | $4,857,862 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
60,573 | $1,971,045 | |
| 6 | EXEL |
Exelixis, Inc.
|
43,450 | $1,863,570 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,720 | $1,214,588 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,468 | $1,134,235 |
All Filings in TOVX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2 | 11 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $2 | 11 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $4 | 11 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $4 | 11 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $12 | 11 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $19 | 11 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $15 | 11 | Shares | Sole | 2025-02-04 | |
| No filing history on record for this holder in this stock. | ||||||